Study of Bafetinib as Treatment for Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Clinical trial NCT01144260 · COMPLETED

Trial details

NCT number: NCT01144260
Sponsor: CytRx
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

B-Cell Chronic Lymphocytic Leukemia

Start date: 2010-06-01
Primary completion: 2011-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.